Vascular Patches Market Research Report by Material (Biologic Vascular Patches, Synthetic Vascular Patches), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms Vascular Bypass Surgery, and Others), End-user (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region–Global Forecast till 2027
ID: MRFR/MED/5189-HCR | February 2021 | Region: Global | 100 pages
Market Overview:
Vascular patches are used for closing sutures in vascular surgeries required for treatment of cardiovascular diseases among others. Effective primary closure of sutures is a crucial factor in all surgical procedures. These patches are produced from biological or synthetic materials and are characterized by excellent biocompatibility with the proven long-term mechanical stability.
Vascular patches have excellent handling properties, and their microporous structure allows proper tissue incorporation. The high elasticity of vascular patches ensures minimum suture hole bleeding with high compliance.
Factors such as the increasing number of vascular surgeries, geriatric population along with the growing adoption of biological patches, and the demand for minimally invasive surgeries drive the market growth of global vascular patches market. On the other hand, factors like the lowering number of carotid endarterectomy surgeries due to the low preference along with the lack of expertise in the manufacturing, mishandling, and applications restrict the market growth.
All these factors presage towards the exponential growth the market is about to witness. The global market of the vascular patches is expected to reach USD 6.1 Bn by the end of 2023, growing at approximately 4.1% CAGR over the forecast period (2018-2023). The market was valued at USD 4.1 billion in 2017.
Although the use of vein patches is considered to be the ‘gold standard’ for patch closure, newer generations of synthetic and biological materials compete with the outcomes associated with vein patches. Futuristic bioengineered patches offer the optimum performance by achieving both, minimal stroke risk and long-term rates of restenosis alongside the minimized risk of unusual complications of prosthetic patches such as infection and pseudoaneurysm formation.
Segmentation:
The Global Vascular Patches Market has been segmented on the basis of material, application, end-user, and regions. By material, the market is segmented into biologic vascular patches and synthetic vascular patches.
Among these, the segment biologic vascular patches account for the major share in 2017, whereas the synthetic vascular patches segment accounts for the fastest growing segment.
By application, the market is segmented into carotid endarterectomy and open repair of abdominal aortic aneurysms vascular bypass surgery
Out of these, the segment carotid endarterectomy accounts for the largest segment, whereas the open repair of abdominal aortic aneurysms vascular bypass surgery is the fastest growing segment.
By end-user, the market is segmented into hospitals & clinics and ambulatory surgical centers, and others. The segment hospitals & Clinics is the largest segment, whereas, the ambulatory surgical centers is the fastest growing segment.
By region, the market is segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. Out of these, the Americas region dominates the market, whereas the Asia Pacific region is touted to grow at a rapid pace during the forecast period.
Regional Analysis
The Americas, led by higher health care expenditures accounts for the significant market share. Factors such as the fastest uptake of newer technologies and devices in the surgical process are some of the essential drivers of the market. The concentration of major producers of vascular patches is fuelling the market growth.
The European region accounts for the second-largest market due to the high disposable income and raising awareness towards the good quality vascular patches.
Whereas, the Asia Pacific region is growing rapidly driven by emerging economies such as India and China.
Gulf nations, particularly, Saudi Arabia and UAE drive the vascular patches market in the Middle Eastern region. The African region is estimated to witness moderate growth owing to poor economic & political conditions and inadequate healthcare facilities.
Key Players
Some of the key players profiled in the report are Terumo Corporation (Japan), C. R. Bard, Inc. (US), B. Braun Melsungen AG (Germany), LeMaitre Vascular, Inc. (US), Maquet (Germany), W. L. Gore & Associates, Inc. (US), Admedus (Australia), CryoLife, Inc. (US), Labcor Laboratórios Ltda (Brazil), Baxter International Inc. (US), and Edwards Lifesciences Corporation (US).
Research Methodology
The research report - Global Vascular Patches Market by Market Research Future (MRFR) comprises an in-depth primary research and the detailed analysis of qualitative as well as quantitative perspectives of various industry experts. Key opinions of market leaders enable to gain a deeper insight of the market performance. The detailed market analysis provides a clearer picture of the current market scenario including past and future market size in terms of value as well as volume alongside the technological advancement, macroeconomy, and governing factors of the market. The report provides detailed information and strategies of topnotch players in the market while providing a broad study of the various segments and regions.
For the scope of research, the report offers a comprehensive analysis of the global vascular patches market.
By Material
- Biologic Vascular Patches
- Synthetic Vascular Patches
By Application
- Carotid Endarterectomy
- Open Repair of Abdominal Aortic Aneurysms Vascular Bypass Surgery
- Others
By End-user
- Hospitals & Clinics
- Ambulatory Surgical Centers
By Region
- Americas
- North America
- The U.S.
- Canada
- South America
- Europe
- Western Europe
- France
- The U.K.
- Germany
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- Qatar
- Oman
- Kuwait
- Saudi Arabia
- United Arab Emirates
- Rest of Middle East & Africa
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | USD 6.1 Bn |
| CAGR | 2018-2023: 4.1% |
| Base Year | 2019 |
| Forecast Period | 2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Material, Application, End-User and Regions |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Terumo Corporation (Japan), C. R. Bard, Inc. (US), B. Braun Melsungen AG (Germany), LeMaitre Vascular, Inc. (US), Maquet (Germany), W. L. Gore & Associates, Inc. (US), Admedus (Australia), CryoLife, Inc. (US), Labcor Laboratórios Ltda (Brazil), Baxter International Inc. (US), and Edwards Lifesciences Corporation (US) |
| Key Market Opportunities |
|
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
vascular patches market is projected to grow at an 4.1% CAGR between 2018-2023.
vascular patches market predicted to touch USD 6.1 billion by 2023.
The Americas is projected to command the largest share in the vascular patches market.
Increasing use of biological patches and rising number of vascular surgeries are adding market growth.
Lack of expertise may limit market growth.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Vascular Patches Market, by Material
6.1 Introduction
6.2 Biologic Vascular Patches
Market Estimates & Forecast by region, 2020-2027
Market Estimates & Forecast country, 2020-2027
6.3 Synthetic Vascular Patches
Market Estimates & Forecast by region, 2020-2027
Market Estimates & Forecast country, 2020-2027
Chapter 7. Global Vascular Patches Market, by Application
7.1 Introduction
7.2 Carotid Endarterectomy
Market Estimates & Forecast by region, 2020-2027
Market Estimates & Forecast country, 2020-2027
7.3 Open Repair of Abdominal Aortic Aneurysms
Market Estimates & Forecast by region, 2020-2027
Market Estimates & Forecast country, 2020-2027
7.4 Vascular Bypass Surgery
Market Estimates & Forecast by region, 2020-2027
Market Estimates & Forecast country, 2020-2027
7.5 Others
Chapter 8. Global Vascular Patches Market, by End user
8.1 Introduction
8.2 Hospitals and Clinics
Market Estimates & Forecast by region, 2020-2027
Market Estimates & Forecast country, 2020-2027
8.3 Ambulatory Surgical Centers
Market Estimates & Forecast by region, 2020-2027
Market Estimates & Forecast country, 2020-2027
Chapter 9. Global Vascular Patches Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 The Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Terumo Corporation
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 C. R. Bard, Inc.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 B. Braun Melsungen AG
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 LeMaitre Vascular, Inc.
11.4.1 Company Overview
11.4.2 Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Maquet
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 W. L. Gore & Associates, Inc.
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Admedus
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 CryoLife, Inc.
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financial Overview
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Labcor Laboratórios Ltda
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financial Overview
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Baxter International Inc.
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financial Overview
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Edwards Lifesciences Corporation
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financial Overview
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of the Vascular Patches Industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Global Vascular Patches Market Synopsis, 2020-2027
Table 2 Global Vascular Patches Market Estimates and Forecast, 2020-2027, (USD Million)
Table 3 Global Vascular Patches Market, by Region, 2020-2027, (USD Million)
Table 4 Global Vascular Patches Market, by Material, 2020-2027, (USD Million)
Table 5 Global Vascular Patches Market, by Application, 2020-2027, (USD Million)
Table 6 Global Vascular Patches Market, by End User, 2020-2027, (USD Million)
Table 7 North America Global Vascular Patches Market, by Material, 2020-2027, (USD Million)
Table 8 North America Global Vascular Patches Market, by Application, 2020-2027,
(USD Million)
Table 9 North America Global Vascular Patches Market, by End User, 2020-2027,
(USD Million)
Table 10 US Vascular Patches Market, by Material, 2020-2027, (USD Million)
Table 11 US Vascular Patches Market, by Application, 2020-2027, (USD Million)
Table 12 US Vascular Patches Market, by End User, 2020-2027, (USD Million)
Table 13 Canada Vascular Patches Market,by Material, 2020-2027, (USD Million)
Table 14 Canada Vascular Patches Market,by Application, 2020-2027, (USD Million)
Table 15 Canada Vascular Patches Market, by End User, 2020-2027, (USD Million)
Table 16 South America Vascular Patches Market, by Material, 2020-2027, (USD
Million)
Table 17 South America Vascular Patches Market, by Application, 2020-2027, (USD
Million)
Table 18 South America Vascular Patches Market, by End User, 2020-2027, (USD
Million)
Table 19 Europe Vascular Patches Market, by Material, 2020-2027, (USD Million)
Table 20 Europe Vascular Patches Market, by Application, 2020-2027, (USD Million)
Table 21 Europe Vascular Patches Market, by End User, 2020-2027, (USD Million)
Table 22 Western Europe Vascular Patches Market, by Material, 2020-2027, (USD
Million)
Table 23 Western Europe Vascular Patches Market, by Application, 2020-2027,
(USD Million)
Table 24 Western Europe Vascular Patches Market, by End User, 2020-2027, (USD
Million)
Table 25 Eastern Europe Vascular Patches Market, by Material, 2020-2027, (USD
Million)
Table 26 Eastern Europe Vascular Patches Market, by Application, 2020-2027, (USD
Million)
Table 27 Eastern Europe Vascular Patches Market, by End User, 2020-2027, (USD
Million)
Table 28 Asia Pacific Vascular Patches Market, by Material, 2020-2027, (USD
Million)
Table 29 Asia Pacific Vascular Patches Market, by Application, 2020-2027, (USD
Million)
Table 30 Asia Pacific Vascular Patches Market, by End User, 2020-2027, (USD
Million)
Table 31 Middle East & Africa Vascular Patches Market, by Material, 2020-2027, (USD
Million)
Table 32 Middle East & Africa Vascular Patches Market, by Application, 2020-2027,
(USD Million)
Table 33 Middle East & Africa Vascular Patches Market, by End User, 2020-2027,
(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Vascular Patches Market
Figure 3 Segmentation Market Dynamics for Global Vascular Patches Market
Figure 4 Global Vascular Patches Market Share, by Material 2020
Figure 5 Global Vascular Patches Market Share, by Application 2020
Figure 6 Global Vascular Patches Market Share, by End User, 2020
Figure 7 Global Vascular Patches Market Share, by Region, 2020
Figure 8 North America Vascular Patches Market Share, by Country, 2020
Figure 9 Europe Vascular Patches Market Share, by Country, 2020
Figure 10 Asia Pacific Vascular Patches Market Share, by Country, 2020
Figure 11 Middle East & Africa Vascular Patches Market Share, by Country, 2020
Figure 12 Global Vascular Patches Market: Company Share Analysis, 2020 (%)
Figure 13 Terumo Corporation: Key Financials
Figure 14 Terumo Corporation: Segmental Revenue
Figure 15 Terumo Corporation: Geographical Revenue
Figure 16 C. R. Bard, Inc.: Key Financials
Figure 17 C. R. Bard, Inc.: Segmental Revenue
Figure 18 C. R. Bard, Inc.: Geographical Revenue
Figure 19 B. Braun Melsungen AG ::Key Financials
Figure 20 B. Braun Melsungen AG : Segmental Revenue
Figure 21 B. Braun Melsungen AG : Geographical Revenue
Figure 22 LeMaitre Vascular, Inc. : Key Financials
Figure 23 LeMaitre Vascular, Inc. : Segmental Revenue
Figure 24 LeMaitre Vascular, Inc. : Geographical Revenue
Figure 25 MAQUET :Key Financials
Figure 26 MAQUET : Segmental Revenue
Figure 27 MAQUET . Geographical Revenue
Figure 28 W. L. Gore & Associates, Inc. : Key Financials
Figure 29 W. L. Gore & Associates, Inc. : Segmental Revenue
Figure 30 W. L. Gore & Associates, Inc. : Geographical Revenue
Figure 31 Admedus: Key Financials
Figure 32 Admedus: Segmental Revenue
Figure 33 Admedus: Geographical Revenue
Figure 35 CryoLife, Inc. : Segmental Revenue
Figure 36 CryoLife, Inc. : Geographical Revenue
Figure 37 CryoLife, Inc. : Key Financials
Figure 38 Labcor Laboratórios Ltda : Segmental Revenue
Figure 39 Labcor Laboratórios Ltda : Geographical Revenue
Figure 40 Labcor Laboratórios Ltda : Key Financials
Figure 41 Baxter International Inc.: Segmental Revenue
Figure 42 Baxter International Inc.: Geographical Revenue
Figure 43 Baxter International Inc.: Key Financials
Figure 44 Edwards Lifesciences Corporation: Segmental Revenue
Figure 45 Edwards Lifesciences Corporation: Geographical Revenue
Figure 46 Edwards Lifesciences Corporation: Key Financials